Skip to main content
2026 CRT Conference Main banner

Howard C. Herrmann, MD, FACC, MSCAI

John Bryfogle Professor Emeritus of Cardiovascular Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Howard C. Herrmann, MD, is the John Bryfogle Professor Emeritus of Medicine of the Perelman School of Medicine at the University of Pennsylvania and former Director of Interventional Cardiology and Cardiac Catheterization. He is a graduate of Harvard College, Harvard Medical School and fellowship training at Massachusetts General Hospital. He has authored more than 500 publications, with a primary research focus on valvular and structural heart disease. He serves on multiple editorial boards and is an Associate Editor of NEJM Clinician. In addition, he consults for several medical technology companies, including serving as Strategic Chief Medical Officer of Carvolinx, Inc. Dr. Herrmann is a past Governor of the Pennsylvania Chapter of the American College of Cardiology and has received the Master designation of the Society for Cardiovascular Angiography and Interventions.

Disclosure(s): Affluent Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Artedrone: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Caranx: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Mass Medical Society: Editorial Fees (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MicroInterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Presentation(s):